Results 121 to 130 of about 5,182 (175)

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis. [PDF]

open access: yesMAbs
Sims GP   +26 more
europepmc   +1 more source

Malondialdehyde-acetaldehyde modified macromolecules and resulting autoantibodies in rheumatoid arthritis pathogenesis: a Systematic Literature Review. [PDF]

open access: yesFront Immunol
Zhou W   +10 more
europepmc   +1 more source

Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study. [PDF]

open access: yesMediterr J Rheumatol
Lini D   +66 more
europepmc   +1 more source

Amorphous calcium carbonate supplementation and bone outcomes in rheumatoid arthritis: A prospective cohort study. [PDF]

open access: yesMedicine (Baltimore)
Chen WS   +8 more
europepmc   +1 more source

Semi-mechanistic modeling to investigate differential dynamics of anti-citrullinated protein antibody (ACPA) IgG versus total IgG reduction following nipocalimab treatment

open access: yesSemi-mechanistic modeling to investigate differential dynamics of anti-citrullinated protein antibody (ACPA) IgG versus total IgG reduction following nipocalimab treatment
Angelia F. Wang   +5 more
openaire   +1 more source

Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease. [PDF]

open access: yesRMD Open
Atzinger A   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy